Benjamin Mullish is a Clinical Research Fellow in the Division of Integrative Systems Medicine and Digestive Disease at Imperial College London and an Honorary Specialty Registrar in Gastroenterology and Hepatology at St Mary's Hospital, Imperial College Healthcare NHS Trust. He is currently studying for a PhD at Imperial College (funded by a MRC Clinical Research Training Fellowship) and was previously an Imperial NIHR-funded Academic Clinical Fellow.
et al., 2019, Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection., Gut
et al., 2018, Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota., Gastroenterology, Vol:155, Pages:1495-1507.e15
et al., 2018, The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines., Gut, Vol:67, Pages:1920-1941
Dhar A, Mullish BH, Thursz MR, 2017, Anticoagulation in chronic liver disease, Journal of Hepatology, Vol:66, ISSN:0168-8278, Pages:1313-1326
et al., 2015, Microbiome manipulation with faecal microbiome transplantation as a therapeutic strategy in Clostridium difficile infection., Qjm, Vol:108, Pages:355-359
Mullish BH, 2014, Case 25-2014: A man with ulcerative colitis and bloody diarrhea., New England Journal of Medicine, Vol:371, ISSN:0028-4793
et al., 2014, Review article: depression and the use of antidepressants in patients with chronic liver disease or liver transplantation, Alimentary Pharmacology & Therapeutics, Vol:40, ISSN:0269-2813, Pages:880-892